Keywords: Mylan, Pfizer, Caduet, Lipitor, Patent settlement, Pay-for-delay

Mylan in patent settlement deals with Pfizer over Caduet and Lipitor

Article | 26 January 2011

Print This

US generics drug major Mylan (Nasdaq: MYL) says that it has entered into two patent settlement agreement with global pharma ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in